The COVID-19 pandemic has been one of the world's worst public health emergencies in living memory and has affected all aspects of life around the world. The pandemic has also propelled awareness of antimicrobial technology and antimicrobial products to new heights. Players in the antimicrobial technology market are developing antimicrobial additives and antimicrobial coatings to meet unprecedented demand for new antimicrobial products, with industry players seeing double-, triple-, or even quadruple-digit growth.

 

Antimicrobial technologies, as covered in this IDTechEx report, refers to antimicrobial additives and antimicrobial coatings that decrease or even eliminate the activity of microorganisms, including bacteria, virus, and fungi. While regular cleaning can remove and kill the microorganisms present on a surface, antimicrobial technologies offer continuous protection between cleans.

 

But even before the COVID-19 pandemic, antimicrobial technologies have been saving lives and money across a broad number of sectors. A key driver for the use of antimicrobial technologies is their ability to address hospital-acquired infections (or healthcare-associated infections). When used in healthcare facilities such as hospitals, antimicrobial technologies have been demonstrated to significantly decrease the rates of infection. By doing so, thousands if not tens of thousands of deaths can be prevented, and billions of dollars can be saved.

 

There are many opportunities beyond the healthcare sector, including food, agriculture, aquaculture, construction (including HVAC systems), and public settings. The use of antimicrobial paints, antimicrobial coatings and antimicrobial additives in the built environment can not only extend the lifetime of the protected product, but also indirectly improve human health through addressing indoor air quality. Antimicrobial textiles can provide anti-odour effect to clothing, curtains, carpets, and soft furnishings. With the world moving against the prophylactic use of antibiotics in agriculture, antimicrobial companies are beginning to fill in the gap. And now, the COVID-19 pandemic has shed light on the importance of cleaning high-touch surfaces in public settings, and the role of antimicrobial technologies in providing safe environments for people in a post-pandemic world.

 

This report takes a deep dive into key antimicrobial technologies. The mechanism of action of each antimicrobial technology is explained and a comparison of efficacy claims from companies commercializing antimicrobial technologies is provided. Profiles of both major and emerging players, including primary interviews, are included in the report.

 

The key antimicrobial technologies covered in the report are:

 

The report also highlights a further 10 antimicrobial technologies either commercialized or in development, including new materials, innovative methods to stabilize and localize traditional disinfectants, biomimetic technologies such as surface patterning techniques, and antimicrobials derived from nature, such as enzymes, peptides, and dyes.

 

IDTechEx have identified over 100 companies that are actively developing antimicrobial technologies and products, including over 60 companies focused entirely in this area. Discussion on market sizing, market outlook, market forecast, and the effect of the COVID-19 pandemic are also included in the report.

 

The information provided in this report will be helpful to those seeking to follow this rising antimicrobial trend by clarifying considerations in developing antimicrobial technology. While technologies may appear similar at first glance, the pandemic is driving a rise in companies looking to make quick wins by operating in grey areas. With public awareness at an all-time high, now is the time to develop environmentally responsible, sustainable, effective, and future-proof antimicrobial products. Antimicrobial technologies have significant potential beyond exiting the COVID-19 pandemic safely, but can also bring about worse problems when used incorrectly.

모든 보고서 구입에는 전문가 분석가와의 최대 30분의 전화통화 시간이 포함되어, 보고서의 주요 결과를 귀하가 제시하는 비즈니스 문제에 연결하도록 돕습니다. 이 전화통화는 보고서를 구매한 후 3개월 이내에 사용해야합니다.

이 보고서에 대해 궁금한 점이 있으시면 언제든지 research@IDTechEx.com으로 보고서 팀에 문의하거나, 영업 관리자에게 문의하십시오

AMERICAS (USA): +1 617 577 7890

ASIA (Japan): +81 3 3216 7209

ASIA (Korea): +82 10 3896 6219

ASIA: +81 70 3152 1209

EUROPE (UK) +44 1223 812300